Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans.
暂无分享,去创建一个
[1] M. Weinstein,et al. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. , 2005, Vaccine.
[2] G. Lindahl,et al. Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens , 2005, Clinical Microbiology Reviews.
[3] C. Baker,et al. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. , 2003, Vaccine.
[4] L. Madoff,et al. Vaccines to prevent neonatal GBS infection. , 2002, Seminars in neonatology : SN.
[5] D. Kasper,et al. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. , 2002, The Journal of infectious diseases.
[6] C. Adair,et al. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. , 2001, The Journal of infectious diseases.
[7] M. Krohn,et al. Group B Streptococcal Colonization and Serotype‐Specific Immunity in Pregnant Women at Delivery , 2000, Obstetrics and gynecology.
[8] C. Leclerc,et al. Reduced Response to Multiple Vaccines Sharing Common Protein Epitopes That Are Administered Simultaneously to Infants , 1998, Infection and Immunity.
[9] A. Schuchat,et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. , 1998, The Journal of infectious diseases.
[10] D. Kasper,et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1996, The Journal of clinical investigation.
[11] D. Kasper,et al. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. , 1994, The Journal of clinical investigation.
[12] D. Kasper,et al. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein , 1992, Infection and immunity.
[13] F. Ausubel,et al. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity , 1991, Infection and immunity.
[14] L. Bevanger,et al. Mouse-protective antibodies against the Ibc proteins of group B streptococci. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.
[15] Dwight R. Johnson,et al. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes , 1984, Journal of clinical microbiology.
[16] D. Kasper,et al. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. , 1981, Pediatrics.
[17] D. Kasper,et al. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. , 1976, The New England journal of medicine.
[18] M. Mccarty,et al. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens , 1975, The Journal of experimental medicine.